
RoX is a digital health innovation studio of the Roche Group
combining startup agility with the scale and strategic depth of a global pharmaceutical and diagnostics company.

We explore, test and validate new digital health business models
through real-world pilots with startups, innovators and healthcare partners.

Acting as a bridge between digital health ecosystems and Roche, we turn fast experiments into scalable solutions
to create meaningful impact for patients.

RoX operates at the intersection of startups, healthcare systems and the Roche Group. Our role is to connect emerging innovation with Roche's global capabilities and translate promising ideas into scalable healthcare solutions.
Working with startups, innovators and healthcare partners, we create environments where new digital health concepts can be tested, validated and prepared for scale.
Through access to expertise, networks and industry insight, we support partners along the journey from early validation to scalable innovation.


We focus on digital health business models that extend beyond traditional pharmaceutical and diagnostics products.
Our work centers on early- to growth-stage ventures with strong ecosystem relevance and the potential for scalability and strategic fit with Roche.
Based in Germany and connected to a global network of partners and experts, we combine local depth with international collaboration.
We enable fast, real-world experimentation through pilots and collaborative innovation environments in a sandbox setting, allowing new ideas to be tested and refined early while reducing development risk.
Our partners benefit from access to Roche's global ecosystem across clinical, technological and commercial expertise — combined with a clear pathway from experimentation to scalable solutions.
We operate with an entrepreneurial mindset — outcome-driven, independent in our execution and focused on bringing together the expertise needed to turn ideas into real-world impact.

Through this approach, we generate scalable business models and actionable insights for investment and business decisions.
At the same time, we enable our partners to become value-creating contributors within Roche's innovation ecosystem, advancing better outcomes for patients and healthcare systems.

Cardiometabolic risks represent a major global health challenge with a growing need for innovative solutions. We focus on diseases like heart failure, obesity and hypertension, where digital approaches can drive meaningful improvements.
Advancing diagnostics and interventions reach their full potential through digital integration, enabling early detection and securing the critical window of opportunity. Here, we focus on Alzheimer's.
Digital pathology is set to transform cancer screening and diagnostics. We invest in solutions that deliver real value for patients and care teams, and we foster strong collaboration between clinicians, laboratories, and industry partners.


Reesi streamlines clinical research in oncology by providing sponsors, patients and study sites with an AI-driven platform that accelerates patient matching to trials, enhancing the efficiency and effectiveness in trial selection.

MindAhead is a therapy app based on behavioral activation, specifically designed for individuals with mild cognitive impairment and mild dementia. With a scientifically-based behavioral activation program, it directly combats memory loss and empowers you to take control of your life.

Always-on Triage (AoT) is a joint project between RoX, Johanniter-Kliniken Bonn GmbH, Roche Diagnostics, and partner companies like Luscii and DoctorBox. The initiative aims to optimize cancer care with an integrated home testing solution, enabling oncology patients to receive hospital-level care in the comfort of their homes.

BeyondX is a digital platform designed to provide comprehensive support and insight to cancer patients, empowering them to make informed decisions about family planning.

eve&i is set out to provide holistic support for women in (peri-)menopause offering personalised information, guidance and valuable access to experts.
Turning Experiments into Scalable Impact.

Olivier drives RoX Health's strategic direction and leads the team. With his deep medical and market access expertise, he strengthens our network with payers, health institutions and key healthcare stakeholders.

Gabriel is heading our operations and is our point of contact for investors. He is an expert in the evaluation of business ideas in all areas of indication.

Gregor leads our portfolio management and strategic innovation alignment. He ensures that RoX focuses on the most impactful opportunities and transforms early signals into scalable business models.

Anni is your first contact at RoX. She is responsible for the daily management of the business.

Johanna conceptualizes, builds and tests solutions in the cardiovascular-metabolic space to establish an obesity ecosystem.

With her long-standing expertise in Regulatory Affairs for Software Devices, Anja facilitates Regulatory Strategy and Regulatory Compliance in all of RoX projects.

Markus ist responsible for our cardiovascular strategy, leading our activities towards an obesity ecosystem.

Nikos leads our Business Development and Breakthrough Exploration Program, identifying and advancing new growth opportunities.

Jonas manages and evolves our IT landscape while driving dedicated technology project streams like RoX FoX. He brings strong expertise in software development to advance our innovation efforts.

Florian works at the intersection of Cardiovascular, Renal and Metabolism (CVRM) and IT, using his technical background to turn ideas into practical solutions.

Maike leads our B2B2C initiatives, developing and orchestrating a cross-sector ecosystem that brings together business partners, laboratories, and consumers to enhance patient outcomes and access to care.
Our various partners value our collaborations at eye level.
"neotiv and RoX share the vision of a long-term strategy in the field of cognitive health that goes hand in hand with the opportunities offered by digitalization in medicine. The aim is to implement innovative products in order to enable holistic care that is integrated into people's lives. Therefore, the expertise and knowledge of RoX accelerates our efforts to build the gateway to prevention and intervention of cognitive diseases."

"Through our own efforts, we became market-ready and accepted. With RoX as our partner, we now have the opportunity to scale significantly and broadly in a way that is truly unique. We are particularly impressed by the team’s deep and wide-ranging expertise as well as its internationally connected, cross-industry network. And all of this comes with a collaborative culture that is not only highly professional but also great fun to work with — creating additional, meaningful momentum."

"RoX Health kennt die Kultur von Start-ups, Großunternehmen und Gesundheitsbehörden. Gepaart mit seinen interdisziplinären Kompetenzen ist Rox Health so ein strategisch wichtiger Partner, um Oculocare medical nachhaltig erfolgreich im Gesundheitsmarkt zu positionieren."
"Since the founding of MindAhead, RoX has been a valuable partner to MindAhead, providing expert support in the complex areas of regulation, product development, and market access. Through this fruitful collaboration, we have been able to develop a state-of-the-art platform for early detection and digital behavioral therapy for cognitive disorders. Our continued partnership with RoX is a testament to our shared vision of improving the lives of those affected by cognitive impairment, and we look forward to achieving great success together."
"Having RoX as a strategic partner makes the world of a difference on various dimensions. Firstly, it adds credibility in an industry where trust is paramount and understanding the merits of an early-stage venture is hard for most investors and partners. Secondly, it is incredibly valuable to have such a pragmatic and easy access to the Roche ecosystem with its deep expertise. Finally, and most importantly, it's always refreshing to be surrounded by so many good-hearted people."
"With RoX, we share the joint vision of making healthcare more patient-centric and accessible. They are a truly valuable strategic partner enabling us to speed up our growth in international markets and expand the use of our technology in promising new areas such as pharma and digital therapeutics."

"We met Rox Health shortly before Helga Health was founded. What unites us is the will to improve the quality of life of oncological patients and their families. Helga stands for easily accessible and digitally supported psycho-oncological support. With the support of the Rox team, we aim to establish innovative psycho-oncological services in German-speaking countries for the benefit of patients and their families. What we particularly appreciate about the cooperation is to put it simply: it's human! An invaluable asset in the healthcare sector."
For any media enquiries, please contact

"RoX Health offers startups expertise and networks along the entire startup journey touching relevant aspects of organisational and portfolio development, market access and commercialisation."
"Die Zukunft der Gesundheitsversorgung wird geprägt sein durch Kooperationen von Industrie und innovativen Playern – in Zusammenarbeit und durch offene Netzwerk."» Visionäre d. Ges.

"Die Zukunft beginnt jetzt – wie wir durch Kooperationen und Netzwerke die Gesundheitsversorgung von morgen mitgestalten."

"Wie digitale Gesundheitslösungen PatientInnen und Arztpraxis erreichen."

"Der Weg zum lernenden Gesundheitssystem: Wie digitale Gesundheitsanwendungen Behandlungen heute und morgen verbessern können"
Join us in revolutionizing digital health. Whether you're a startup, healthcare provider, or industry partner, let's connect and create impactful solutions together.